Patents Assigned to Levicept Limited
  • Therapeutic use of p75NTR neurotrophin binding protein
    Patent number: 11339202
    Abstract: The present invention relates to a new therapeutic use of a p75NTR neurotrophin binding protein and related molecules in the treatment of osteoarthritis.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: May 24, 2022
    Assignee: LEVICEPT LIMITED
    Inventor: Simon Westbrook
  • DNA molecule encoding a p75NTR(NBP)-Fc fusion protein
    Patent number: 10988526
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR(NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: April 27, 2021
    Assignee: Levicept Limited
    Inventor: Simon Westbrook
  • P75NTR binding protein-Fc fusion protein and methods of treating pain
    Patent number: 10683339
    Abstract: The present invention relates to a new p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR (NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR (NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: June 16, 2020
    Assignee: Levicept Limited
    Inventor: Simon Westbrook